Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Systems Biology|December 26, 2006
Decreased internalisation of erbB1 mutants in lung cancer is linked with a mechanism conferring sensitivity to gefitinibB S Hendriks, G J Griffiths, R Benson, et al.
The Journal of Nutrition, Health & Aging|August 25, 2024
The relation between preoperative radiological sarcopenia and postoperative recovery of physical activity in older surgical cancer patients; an explorative studyS Hendriks, M G Huisman, L Weerink, et al.
The American Journal of Pathology|September 17, 2013
Single-cell quantitative HER2 measurement identifies heterogeneity and distinct subgroups within traditionally defined HER2-positive patientsMatthew D Onsum, Elena Geretti, Violette Paragas, et al.
Archives of Toxicology|September 26, 2014
Effects of neonatal exposure to the flame retardant tetrabromobisphenol-A, aluminum diethylphosphinate or zinc stannate on long-term potentiation and synaptic protein levels in miceHester S Hendriks, Lucas A E Koolen, Milou M L Dingemans, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Multiscale kinetic modeling of liposomal Doxorubicin delivery quantifies the role of tumor and drug-specific parameters in local delivery to tumorsB S Hendriks, J G Reynolds, S G Klinz, et al.
Pharmaceutical Research|January 26, 2018
Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast CancerAfroz S Mohammad, Jessica I Griffith, Chris E Adkins, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|January 15, 2010
Maternal and paternal risk factors for anorectal malformations: a Dutch case-control studyIris A L M van Rooij, Charlotte H W Wijers, Paul N M A Rieu, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 10, 2014
A gradient-loadable (64)Cu-chelator for quantifying tumor deposition kinetics of nanoliposomal therapeutics by positron emission tomographyHelen Lee, Jinzi Zheng, Daniel Gaddy, et al.
Anti-Cancer Drugs|September 1, 2017
Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancerShannon C Leonard, Helen Lee, Daniel F Gaddy, et al.
Toxicology and Applied Pharmacology|April 14, 2009
Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicityBenjamin D Cosgrove, Bracken M King, Maya A Hasan, et al.
Pageof 9